FDA Inspection 671734 — BioMarin Pharmaceutical, Inc.
The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on Jul 15, 2010 in Novato, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 15, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Novato, CA (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)